Literature DB >> 2228716

Systemic dissemination of Pneumocystis carinii in a patient with acquired immunodeficiency syndrome.

M B Amin1, M P Abrash, E Mezger, G F Sekerak.   

Abstract

Pneumocystis carinii is usually considered a respiratory tract pathogen; however, there are reported cases of limited and generalized dissemination of the organism from the lungs of immunocompromised patients. We present the autopsy findings of a 29-year-old male with acquired immunodeficiency syndrome (AIDS) and recurrent Pneumocystis carinii pneumonia who developed abnormal liver function tests. The patient had received aerosolized pentamidine because of toxic reactions to other modes of therapy. The postmortem examination revealed Pneumocystis in the lungs, liver, spleen, kidney, myocardium, thymus, pancreas, thyroid gland, bilateral parathyroid and adrenal glands, gastrointestinal mucosa, perihilar and mesenteric lymph nodes, and bone marrow. A high index of suspicion, especially in patients treated with aerosolized pentamidine, may lead to an increased recognition of disseminated pneumocystosis. Dissemination of the infection may be due to failure of the aerosolized drug to achieve adequate blood levels. As AIDS patients survive longer because of the developing therapeutic arsenal, disseminated pneumocystosis may be encountered with increasing frequency in these immunocompromised patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228716

Source DB:  PubMed          Journal:  Henry Ford Hosp Med J        ISSN: 0018-0416


  3 in total

Review 1.  [Inflammation of the parathyroid glands].

Authors:  S Ting; S Synoracki; S-Y Sheu; K W Schmid
Journal:  Pathologe       Date:  2016-05       Impact factor: 1.011

2.  A novel variety of atypical Pneumocystis carinii infection after long-term prophylactic pentamidine inhalation in an AIDS patient: large lower lobe pneumocystoma.

Authors:  H Albrecht; H J Stellbrink; S Fenske; J Koch; H Greten
Journal:  Clin Investig       Date:  1993-04

3.  Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection.

Authors:  Steve Searles; Katherine Gauss; Michelle Wilkison; Teri R Hoyt; Erin Dobrinen; Nicole Meissner
Journal:  J Immunol       Date:  2013-08-23       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.